MeSH tree: D04.210.500.745.640
Research from the University of Virginia School of Medicine could pave the way for new treatments to manage migraines and chronic pain in women, improving their quality of life. The work is published in The Journal of Pain.
Feb 21, 2024
0
37
The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.
Dec 15, 2023
0
40
On Aug. 4, 2023, the United States Food and Drug Administration (FDA) approved zuranolone (Zurzuvae) as the first oral neurosteroid treatment for postpartum depression (PPD) in women.
Oct 20, 2023
0
71
While mothers with postpartum depression have always faced barriers accessing the care they need, things have been particularly bad since the onset of the COVID-19 pandemic.
Sep 1, 2023
0
32
The Food and Drug Administration announced Friday its approval of the new drug zuranolone for postpartum depression. The once-daily pill, meant for short-term use, may help those who struggle with the serious, sometimes life-threatening ...
Aug 7, 2023
0
47
The latest generation of antidepressants relieves symptoms by mimicking steroids produced by the brain to ensure neurons are effectively talking to each other. How these neurosteroids are linked to depression and why they ...
Feb 13, 2023
0
67
An Australian drug delivery technology, developed by Monash University researchers in partnership with PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has today released results from a multipart Phase 1 trial of the prodrug ...
Dec 21, 2022
0
64
Pregnancy and birthing have profound, often long-lasting, effects on brain physiology, mood and behavior. New findings on the neurobiology of the maternal experience were presented at Neuroscience 2022, the annual meeting ...
Nov 9, 2022
0
31
In the United States, approximately 1.2 million people are living with human immunodeficiency virus type-1 (HIV-1), with men accounting for the majority of cases (~75%). About half of HIV-infected individuals are 50 years ...
Jul 28, 2022
0
96
